Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1245, 2000-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Early interferon-β-1b of BENEFIT for MS?
Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. :
Access to resources
Recommend
IFN- -1a, IFN- -1b, glatiramer acetate not warranted in MS
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :
IFN- -1a, IFN- -1b, glatiramer acetate not warranted in MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 465, 2004-01 ,pp. :
IFN- cost effective for MS after all?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :
IFN- cost effective for MS after all?
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :